Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net profit, on
WBA Earnings: Walgreens Boots Alliance Q2 profit and sales beat estimates
Categories
Health Care
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring
LatAm healthcare firm Auna prepares for NYSE listing; to raise $420 million in IPO
IPO activity gathered momentum this year in a sign that the market is recovering from the weakness experienced in 2023. The resilience
Earnings Summary: CooperCompanies (COO) reports strong Q1 2024 results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the first quarter of 2024, reporting an increase in revenues and adjusted
Earnings Summary: Dentsply Sirona reports higher sales for Q4 2023
Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting an increase
Earnings: Agilent’s (A) Q1 2024 profit declines on lower revenues
Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when its revenues
Infographic: Highlights of Moderna’s (MRNA) Q4 2023 earnings results
Biotechnology company Moderna, Inc. (NASDAQ: MRNA) reported a sharp decline in revenues and earnings for the fourth quarter of 2023. Net income
Medtronic (MDT) Q3 2024 revenue rises 5%; adj. earnings flat
Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the company's adjusted
Earnings Summary: Organon reports financial results for Q4 2023
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the fourth quarter of 2023. Total revenue
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers and institutions to accelerate the development of new
BIIB Earnings: Here’s everything you need to know about Biogen’s Q4 report
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the fourth quarter of 2023. Total
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy experience. Having
Earnings Summary: Baxter International reports higher Q4 sales and adj. profit
Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher revenues and
CVS Health Q4 2023 adj. earnings rise on higher revenues; guides FY24
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted profit increased
Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter of 2023.
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth
Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion versus the
ABBV Earnings: Everything you need to know about AbbVie’s Q4 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Eli Lilly and Company all set to report Q4 results. Here’s what to expect
Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully diversified beyond